Bill Text: IL HB2508 | 2015-2016 | 99th General Assembly | Introduced


Bill Title: Creates the Right to Try Act. Provides that an eligible patient with a terminal illness who has considered all other treatment options approved by the United States Food and Drug Administration may acquire from a manufacturer an investigational drug, biological product, or device that has successfully completed Phase I of a clinical trial, but has not been approved for general use by the United States Food and Drug Administration. Provides that a manufacturer may, but is not required to, provide an investigational drug, biological product, or device to an eligible patient, either with or without receiving compensation. Provides that an accident and health insurer may, but is not required to, provide coverage for an eligible patient seeking such a drug, product, or device. Contains a penalty provision. Defines required terms. Contains legislative findings. Amends the Medical Practice Act of 1987. Provides that the Department of Financial and Professional Regulation may not revoke, suspend, place on probation, reprimand, refuse to issue or renew, or take any other disciplinary or non-disciplinary action against the license or permit of a physician to practice medicine based solely on the physician's recommendation to an eligible patient regarding, or prescription for, or treatment with an investigational drug, biological product, or device.

Spectrum: Slight Partisan Bill (Democrat 2-1)

Status: (Introduced - Dead) 2015-03-27 - Rule 19(a) / Re-referred to Rules Committee [HB2508 Detail]

Download: Illinois-2015-HB2508-Introduced.html


99TH GENERAL ASSEMBLY
State of Illinois
2015 and 2016
HB2508

Introduced , by Rep. David Harris

SYNOPSIS AS INTRODUCED:
New Act
225 ILCS 60/22 from Ch. 111, par. 4400-22

Creates the Right to Try Act. Provides that an eligible patient with a terminal illness who has considered all other treatment options approved by the United States Food and Drug Administration may acquire from a manufacturer an investigational drug, biological product, or device that has successfully completed Phase I of a clinical trial, but has not been approved for general use by the United States Food and Drug Administration. Provides that a manufacturer may, but is not required to, provide an investigational drug, biological product, or device to an eligible patient, either with or without receiving compensation. Provides that an accident and health insurer may, but is not required to, provide coverage for an eligible patient seeking such a drug, product, or device. Contains a penalty provision. Defines required terms. Contains legislative findings. Amends the Medical Practice Act of 1987. Provides that the Department of Financial and Professional Regulation may not revoke, suspend, place on probation, reprimand, refuse to issue or renew, or take any other disciplinary or non-disciplinary action against the license or permit of a physician to practice medicine based solely on the physician's recommendation to an eligible patient regarding, or prescription for, or treatment with an investigational drug, biological product, or device.
LRB099 09026 JLK 29212 b
CORRECTIONAL BUDGET AND IMPACT NOTE ACT MAY APPLY
FISCAL NOTE ACT MAY APPLY

A BILL FOR

HB2508LRB099 09026 JLK 29212 b
1 AN ACT concerning health.
2 Be it enacted by the People of the State of Illinois,
3represented in the General Assembly:
4 Section 1. Short title. This Act may be cited as the Right
5to Try Act.
6 Section 5. Findings. The General Assembly finds that the
7process of approval for investigational drugs, biological
8products, and devices in the United States often takes many
9years, and a patient with a terminal illness does not have the
10luxury of waiting until such drug, product, or device receives
11final approval from the United States Food and Drug
12Administration. As a result, the standards of the United States
13Food and Drug Administration for the use of investigational
14drugs, biological products, and devices may deny the benefits
15of potentially life-saving treatments to terminally ill
16patients. A patient with a terminal illness has a fundamental
17right to attempt to preserve his or her own life by accessing
18investigational drugs, biological products, and devices.
19Whether to use available investigational drugs, biological
20products, and devices is a decision that rightfully should be
21made by the patient with a terminal illness in consultation
22with his or her physician and is not a decision to be made by
23the government.

HB2508- 2 -LRB099 09026 JLK 29212 b
1 Section 10. Definitions. For the purposes of this Act:
2 "Accident and health insurer" has the meaning given to that
3term in Section 126.2 of the Illinois Insurance Code.
4 "Eligible patient" means a person who:
5 (1) has a terminal illness;
6 (2) has considered all other treatment options
7 approved by the United States Food and Drug Administration;
8 (3) has received a prescription or recommendation from
9 his or her physician for an investigational drug,
10 biological product, or device;
11 (4) has given his or her informed consent in writing
12 for the use of the investigational drug, biological
13 product, or device or, if he or she is a minor or lacks the
14 mental capacity to provide informed consent, a parent or
15 legal guardian has given informed consent on his or her
16 behalf; and
17 (5) has documentation from his or her physician
18 indicating that he or she has met the requirements of this
19 Act.
20 "Investigational drug, biological product, or device"
21means a drug, biological product, or device that has
22successfully completed Phase I of a clinical trial, but has not
23been approved for general use by the United States Food and
24Drug Administration.
25 "Phase I of a clinical trial" means the stage of a clinical

HB2508- 3 -LRB099 09026 JLK 29212 b
1trial where an investigational drug, biological product, or
2device that has been tested in a small group for the first time
3to evaluate its safety, determine a safe dosage range, and
4identify side effects.
5 "Terminal illness" means a disease that, without
6life-sustaining measures, can reasonably be expected to result
7in death in 24 months or less.
8 Section 15. Availability of drugs, biological products,
9and devices.
10 (a) A manufacturer of an investigational drug, biological
11product, or device may make available such drug, product, or
12device to eligible patients. Nothing in this Act shall be
13construed to require a manufacturer to make available any drug,
14product, or device.
15 (b) A manufacturer may:
16 (1) provide an investigational drug, biological
17 product, or device to an eligible patient without receiving
18 compensation; or
19 (2) require an eligible patient to pay the costs of or
20 associated with the manufacture of the investigational
21 drug, biological product, or device.
22 Section 20. Insurance coverage. An accident and health
23insurer may choose to provide coverage for the cost of an
24investigational drug, biological product, or device. Nothing

HB2508- 4 -LRB099 09026 JLK 29212 b
1in this Act shall be construed to require an accident and
2health insurer to provide coverage for the cost of any
3investigational drug, biological product, or device.
4 Section 25. Penalty. Any official, employee, or agent of
5the State who blocks or attempts to block access by an eligible
6patient to an investigational drug, biological product, or
7device shall be guilty of a misdemeanor, punishable by a fine
8not to exceed $1,500.
9 Section 30. The Medical Practice Act of 1987 is amended by
10changing Section 22 as follows:
11 (225 ILCS 60/22) (from Ch. 111, par. 4400-22)
12 (Section scheduled to be repealed on December 31, 2015)
13 Sec. 22. Disciplinary action.
14 (A) The Department may revoke, suspend, place on probation,
15reprimand, refuse to issue or renew, or take any other
16disciplinary or non-disciplinary action as the Department may
17deem proper with regard to the license or permit of any person
18issued under this Act, including imposing fines not to exceed
19$10,000 for each violation, upon any of the following grounds:
20 (1) Performance of an elective abortion in any place,
21 locale, facility, or institution other than:
22 (a) a facility licensed pursuant to the Ambulatory
23 Surgical Treatment Center Act;

HB2508- 5 -LRB099 09026 JLK 29212 b
1 (b) an institution licensed under the Hospital
2 Licensing Act;
3 (c) an ambulatory surgical treatment center or
4 hospitalization or care facility maintained by the
5 State or any agency thereof, where such department or
6 agency has authority under law to establish and enforce
7 standards for the ambulatory surgical treatment
8 centers, hospitalization, or care facilities under its
9 management and control;
10 (d) ambulatory surgical treatment centers,
11 hospitalization or care facilities maintained by the
12 Federal Government; or
13 (e) ambulatory surgical treatment centers,
14 hospitalization or care facilities maintained by any
15 university or college established under the laws of
16 this State and supported principally by public funds
17 raised by taxation.
18 (2) Performance of an abortion procedure in a wilful
19 and wanton manner on a woman who was not pregnant at the
20 time the abortion procedure was performed.
21 (3) A plea of guilty or nolo contendere, finding of
22 guilt, jury verdict, or entry of judgment or sentencing,
23 including, but not limited to, convictions, preceding
24 sentences of supervision, conditional discharge, or first
25 offender probation, under the laws of any jurisdiction of
26 the United States of any crime that is a felony.

HB2508- 6 -LRB099 09026 JLK 29212 b
1 (4) Gross negligence in practice under this Act.
2 (5) Engaging in dishonorable, unethical or
3 unprofessional conduct of a character likely to deceive,
4 defraud or harm the public.
5 (6) Obtaining any fee by fraud, deceit, or
6 misrepresentation.
7 (7) Habitual or excessive use or abuse of drugs defined
8 in law as controlled substances, of alcohol, or of any
9 other substances which results in the inability to practice
10 with reasonable judgment, skill or safety.
11 (8) Practicing under a false or, except as provided by
12 law, an assumed name.
13 (9) Fraud or misrepresentation in applying for, or
14 procuring, a license under this Act or in connection with
15 applying for renewal of a license under this Act.
16 (10) Making a false or misleading statement regarding
17 their skill or the efficacy or value of the medicine,
18 treatment, or remedy prescribed by them at their direction
19 in the treatment of any disease or other condition of the
20 body or mind.
21 (11) Allowing another person or organization to use
22 their license, procured under this Act, to practice.
23 (12) Adverse action taken by another state or
24 jurisdiction against a license or other authorization to
25 practice as a medical doctor, doctor of osteopathy, doctor
26 of osteopathic medicine or doctor of chiropractic, a

HB2508- 7 -LRB099 09026 JLK 29212 b
1 certified copy of the record of the action taken by the
2 other state or jurisdiction being prima facie evidence
3 thereof. This includes any adverse action taken by a State
4 or federal agency that prohibits a medical doctor, doctor
5 of osteopathy, doctor of osteopathic medicine, or doctor of
6 chiropractic from providing services to the agency's
7 participants.
8 (13) Violation of any provision of this Act or of the
9 Medical Practice Act prior to the repeal of that Act, or
10 violation of the rules, or a final administrative action of
11 the Secretary, after consideration of the recommendation
12 of the Disciplinary Board.
13 (14) Violation of the prohibition against fee
14 splitting in Section 22.2 of this Act.
15 (15) A finding by the Disciplinary Board that the
16 registrant after having his or her license placed on
17 probationary status or subjected to conditions or
18 restrictions violated the terms of the probation or failed
19 to comply with such terms or conditions.
20 (16) Abandonment of a patient.
21 (17) Prescribing, selling, administering,
22 distributing, giving or self-administering any drug
23 classified as a controlled substance (designated product)
24 or narcotic for other than medically accepted therapeutic
25 purposes.
26 (18) Promotion of the sale of drugs, devices,

HB2508- 8 -LRB099 09026 JLK 29212 b
1 appliances or goods provided for a patient in such manner
2 as to exploit the patient for financial gain of the
3 physician.
4 (19) Offering, undertaking or agreeing to cure or treat
5 disease by a secret method, procedure, treatment or
6 medicine, or the treating, operating or prescribing for any
7 human condition by a method, means or procedure which the
8 licensee refuses to divulge upon demand of the Department.
9 (20) Immoral conduct in the commission of any act
10 including, but not limited to, commission of an act of
11 sexual misconduct related to the licensee's practice.
12 (21) Wilfully making or filing false records or reports
13 in his or her practice as a physician, including, but not
14 limited to, false records to support claims against the
15 medical assistance program of the Department of Healthcare
16 and Family Services (formerly Department of Public Aid)
17 under the Illinois Public Aid Code.
18 (22) Wilful omission to file or record, or wilfully
19 impeding the filing or recording, or inducing another
20 person to omit to file or record, medical reports as
21 required by law, or wilfully failing to report an instance
22 of suspected abuse or neglect as required by law.
23 (23) Being named as a perpetrator in an indicated
24 report by the Department of Children and Family Services
25 under the Abused and Neglected Child Reporting Act, and
26 upon proof by clear and convincing evidence that the

HB2508- 9 -LRB099 09026 JLK 29212 b
1 licensee has caused a child to be an abused child or
2 neglected child as defined in the Abused and Neglected
3 Child Reporting Act.
4 (24) Solicitation of professional patronage by any
5 corporation, agents or persons, or profiting from those
6 representing themselves to be agents of the licensee.
7 (25) Gross and wilful and continued overcharging for
8 professional services, including filing false statements
9 for collection of fees for which services are not rendered,
10 including, but not limited to, filing such false statements
11 for collection of monies for services not rendered from the
12 medical assistance program of the Department of Healthcare
13 and Family Services (formerly Department of Public Aid)
14 under the Illinois Public Aid Code.
15 (26) A pattern of practice or other behavior which
16 demonstrates incapacity or incompetence to practice under
17 this Act.
18 (27) Mental illness or disability which results in the
19 inability to practice under this Act with reasonable
20 judgment, skill or safety.
21 (28) Physical illness, including, but not limited to,
22 deterioration through the aging process, or loss of motor
23 skill which results in a physician's inability to practice
24 under this Act with reasonable judgment, skill or safety.
25 (29) Cheating on or attempt to subvert the licensing
26 examinations administered under this Act.

HB2508- 10 -LRB099 09026 JLK 29212 b
1 (30) Wilfully or negligently violating the
2 confidentiality between physician and patient except as
3 required by law.
4 (31) The use of any false, fraudulent, or deceptive
5 statement in any document connected with practice under
6 this Act.
7 (32) Aiding and abetting an individual not licensed
8 under this Act in the practice of a profession licensed
9 under this Act.
10 (33) Violating state or federal laws or regulations
11 relating to controlled substances, legend drugs, or
12 ephedra as defined in the Ephedra Prohibition Act.
13 (34) Failure to report to the Department any adverse
14 final action taken against them by another licensing
15 jurisdiction (any other state or any territory of the
16 United States or any foreign state or country), by any peer
17 review body, by any health care institution, by any
18 professional society or association related to practice
19 under this Act, by any governmental agency, by any law
20 enforcement agency, or by any court for acts or conduct
21 similar to acts or conduct which would constitute grounds
22 for action as defined in this Section.
23 (35) Failure to report to the Department surrender of a
24 license or authorization to practice as a medical doctor, a
25 doctor of osteopathy, a doctor of osteopathic medicine, or
26 doctor of chiropractic in another state or jurisdiction, or

HB2508- 11 -LRB099 09026 JLK 29212 b
1 surrender of membership on any medical staff or in any
2 medical or professional association or society, while
3 under disciplinary investigation by any of those
4 authorities or bodies, for acts or conduct similar to acts
5 or conduct which would constitute grounds for action as
6 defined in this Section.
7 (36) Failure to report to the Department any adverse
8 judgment, settlement, or award arising from a liability
9 claim related to acts or conduct similar to acts or conduct
10 which would constitute grounds for action as defined in
11 this Section.
12 (37) Failure to provide copies of medical records as
13 required by law.
14 (38) Failure to furnish the Department, its
15 investigators or representatives, relevant information,
16 legally requested by the Department after consultation
17 with the Chief Medical Coordinator or the Deputy Medical
18 Coordinator.
19 (39) Violating the Health Care Worker Self-Referral
20 Act.
21 (40) Willful failure to provide notice when notice is
22 required under the Parental Notice of Abortion Act of 1995.
23 (41) Failure to establish and maintain records of
24 patient care and treatment as required by this law.
25 (42) Entering into an excessive number of written
26 collaborative agreements with licensed advanced practice

HB2508- 12 -LRB099 09026 JLK 29212 b
1 nurses resulting in an inability to adequately
2 collaborate.
3 (43) Repeated failure to adequately collaborate with a
4 licensed advanced practice nurse.
5 (44) Violating the Compassionate Use of Medical
6 Cannabis Pilot Program Act.
7 (45) Entering into an excessive number of written
8 collaborative agreements with licensed prescribing
9 psychologists resulting in an inability to adequately
10 collaborate.
11 (46) Repeated failure to adequately collaborate with a
12 licensed prescribing psychologist.
13 Except for actions involving the ground numbered (26), all
14proceedings to suspend, revoke, place on probationary status,
15or take any other disciplinary action as the Department may
16deem proper, with regard to a license on any of the foregoing
17grounds, must be commenced within 5 years next after receipt by
18the Department of a complaint alleging the commission of or
19notice of the conviction order for any of the acts described
20herein. Except for the grounds numbered (8), (9), (26), and
21(29), no action shall be commenced more than 10 years after the
22date of the incident or act alleged to have violated this
23Section. For actions involving the ground numbered (26), a
24pattern of practice or other behavior includes all incidents
25alleged to be part of the pattern of practice or other behavior
26that occurred, or a report pursuant to Section 23 of this Act

HB2508- 13 -LRB099 09026 JLK 29212 b
1received, within the 10-year period preceding the filing of the
2complaint. In the event of the settlement of any claim or cause
3of action in favor of the claimant or the reduction to final
4judgment of any civil action in favor of the plaintiff, such
5claim, cause of action or civil action being grounded on the
6allegation that a person licensed under this Act was negligent
7in providing care, the Department shall have an additional
8period of 2 years from the date of notification to the
9Department under Section 23 of this Act of such settlement or
10final judgment in which to investigate and commence formal
11disciplinary proceedings under Section 36 of this Act, except
12as otherwise provided by law. The time during which the holder
13of the license was outside the State of Illinois shall not be
14included within any period of time limiting the commencement of
15disciplinary action by the Department.
16 The entry of an order or judgment by any circuit court
17establishing that any person holding a license under this Act
18is a person in need of mental treatment operates as a
19suspension of that license. That person may resume their
20practice only upon the entry of a Departmental order based upon
21a finding by the Disciplinary Board that they have been
22determined to be recovered from mental illness by the court and
23upon the Disciplinary Board's recommendation that they be
24permitted to resume their practice.
25 The Department may refuse to issue or take disciplinary
26action concerning the license of any person who fails to file a

HB2508- 14 -LRB099 09026 JLK 29212 b
1return, or to pay the tax, penalty or interest shown in a filed
2return, or to pay any final assessment of tax, penalty or
3interest, as required by any tax Act administered by the
4Illinois Department of Revenue, until such time as the
5requirements of any such tax Act are satisfied as determined by
6the Illinois Department of Revenue.
7 The Department, upon the recommendation of the
8Disciplinary Board, shall adopt rules which set forth standards
9to be used in determining:
10 (a) when a person will be deemed sufficiently
11 rehabilitated to warrant the public trust;
12 (b) what constitutes dishonorable, unethical or
13 unprofessional conduct of a character likely to deceive,
14 defraud, or harm the public;
15 (c) what constitutes immoral conduct in the commission
16 of any act, including, but not limited to, commission of an
17 act of sexual misconduct related to the licensee's
18 practice; and
19 (d) what constitutes gross negligence in the practice
20 of medicine.
21 However, no such rule shall be admissible into evidence in
22any civil action except for review of a licensing or other
23disciplinary action under this Act.
24 In enforcing this Section, the Disciplinary Board or the
25Licensing Board, upon a showing of a possible violation, may
26compel, in the case of the Disciplinary Board, any individual

HB2508- 15 -LRB099 09026 JLK 29212 b
1who is licensed to practice under this Act or holds a permit to
2practice under this Act, or, in the case of the Licensing
3Board, any individual who has applied for licensure or a permit
4pursuant to this Act, to submit to a mental or physical
5examination and evaluation, or both, which may include a
6substance abuse or sexual offender evaluation, as required by
7the Licensing Board or Disciplinary Board and at the expense of
8the Department. The Disciplinary Board or Licensing Board shall
9specifically designate the examining physician licensed to
10practice medicine in all of its branches or, if applicable, the
11multidisciplinary team involved in providing the mental or
12physical examination and evaluation, or both. The
13multidisciplinary team shall be led by a physician licensed to
14practice medicine in all of its branches and may consist of one
15or more or a combination of physicians licensed to practice
16medicine in all of its branches, licensed chiropractic
17physicians, licensed clinical psychologists, licensed clinical
18social workers, licensed clinical professional counselors, and
19other professional and administrative staff. Any examining
20physician or member of the multidisciplinary team may require
21any person ordered to submit to an examination and evaluation
22pursuant to this Section to submit to any additional
23supplemental testing deemed necessary to complete any
24examination or evaluation process, including, but not limited
25to, blood testing, urinalysis, psychological testing, or
26neuropsychological testing. The Disciplinary Board, the

HB2508- 16 -LRB099 09026 JLK 29212 b
1Licensing Board, or the Department may order the examining
2physician or any member of the multidisciplinary team to
3provide to the Department, the Disciplinary Board, or the
4Licensing Board any and all records, including business
5records, that relate to the examination and evaluation,
6including any supplemental testing performed. The Disciplinary
7Board, the Licensing Board, or the Department may order the
8examining physician or any member of the multidisciplinary team
9to present testimony concerning this examination and
10evaluation of the licensee, permit holder, or applicant,
11including testimony concerning any supplemental testing or
12documents relating to the examination and evaluation. No
13information, report, record, or other documents in any way
14related to the examination and evaluation shall be excluded by
15reason of any common law or statutory privilege relating to
16communication between the licensee, permit holder, or
17applicant and the examining physician or any member of the
18multidisciplinary team. No authorization is necessary from the
19licensee, permit holder, or applicant ordered to undergo an
20evaluation and examination for the examining physician or any
21member of the multidisciplinary team to provide information,
22reports, records, or other documents or to provide any
23testimony regarding the examination and evaluation. The
24individual to be examined may have, at his or her own expense,
25another physician of his or her choice present during all
26aspects of the examination. Failure of any individual to submit

HB2508- 17 -LRB099 09026 JLK 29212 b
1to mental or physical examination and evaluation, or both, when
2directed, shall result in an automatic suspension, without
3hearing, until such time as the individual submits to the
4examination. If the Disciplinary Board or Licensing Board finds
5a physician unable to practice following an examination and
6evaluation because of the reasons set forth in this Section,
7the Disciplinary Board or Licensing Board shall require such
8physician to submit to care, counseling, or treatment by
9physicians, or other health care professionals, approved or
10designated by the Disciplinary Board, as a condition for
11issued, continued, reinstated, or renewed licensure to
12practice. Any physician, whose license was granted pursuant to
13Sections 9, 17, or 19 of this Act, or, continued, reinstated,
14renewed, disciplined or supervised, subject to such terms,
15conditions or restrictions who shall fail to comply with such
16terms, conditions or restrictions, or to complete a required
17program of care, counseling, or treatment, as determined by the
18Chief Medical Coordinator or Deputy Medical Coordinators,
19shall be referred to the Secretary for a determination as to
20whether the licensee shall have their license suspended
21immediately, pending a hearing by the Disciplinary Board. In
22instances in which the Secretary immediately suspends a license
23under this Section, a hearing upon such person's license must
24be convened by the Disciplinary Board within 15 days after such
25suspension and completed without appreciable delay. The
26Disciplinary Board shall have the authority to review the

HB2508- 18 -LRB099 09026 JLK 29212 b
1subject physician's record of treatment and counseling
2regarding the impairment, to the extent permitted by applicable
3federal statutes and regulations safeguarding the
4confidentiality of medical records.
5 An individual licensed under this Act, affected under this
6Section, shall be afforded an opportunity to demonstrate to the
7Disciplinary Board that they can resume practice in compliance
8with acceptable and prevailing standards under the provisions
9of their license.
10 The Department may promulgate rules for the imposition of
11fines in disciplinary cases, not to exceed $10,000 for each
12violation of this Act. Fines may be imposed in conjunction with
13other forms of disciplinary action, but shall not be the
14exclusive disposition of any disciplinary action arising out of
15conduct resulting in death or injury to a patient. Any funds
16collected from such fines shall be deposited in the Medical
17Disciplinary Fund.
18 All fines imposed under this Section shall be paid within
1960 days after the effective date of the order imposing the fine
20or in accordance with the terms set forth in the order imposing
21the fine.
22 (B) The Department shall revoke the license or permit
23issued under this Act to practice medicine or a chiropractic
24physician who has been convicted a second time of committing
25any felony under the Illinois Controlled Substances Act or the
26Methamphetamine Control and Community Protection Act, or who

HB2508- 19 -LRB099 09026 JLK 29212 b
1has been convicted a second time of committing a Class 1 felony
2under Sections 8A-3 and 8A-6 of the Illinois Public Aid Code. A
3person whose license or permit is revoked under this subsection
4B shall be prohibited from practicing medicine or treating
5human ailments without the use of drugs and without operative
6surgery.
7 (C) The Department shall not revoke, suspend, place on
8probation, reprimand, refuse to issue or renew, or take any
9other disciplinary or non-disciplinary action against the
10license or permit issued under this Act to practice medicine to
11a physician based solely upon the recommendation of the
12physician to an eligible patient regarding, or prescription
13for, or treatment with, an investigational drug, biological
14product, or device.
15 (D) (C) The Disciplinary Board shall recommend to the
16Department civil penalties and any other appropriate
17discipline in disciplinary cases when the Board finds that a
18physician willfully performed an abortion with actual
19knowledge that the person upon whom the abortion has been
20performed is a minor or an incompetent person without notice as
21required under the Parental Notice of Abortion Act of 1995.
22Upon the Board's recommendation, the Department shall impose,
23for the first violation, a civil penalty of $1,000 and for a
24second or subsequent violation, a civil penalty of $5,000.
25(Source: P.A. 97-622, eff. 11-23-11; 98-601, eff. 12-30-13;
2698-668, eff. 6-25-14; 98-1140, eff. 12-30-14.)
feedback